Ablevia
biotech
Ablevia removes disease-causing and other undesired antibodies
[(c) stock.adobe.com]
Ablevia biotech GmbH
Maria Jacobi Gasse 1, MQM 3.2
1030 Vienna
AUSTRIA
contact us
member of
funding
& partners
supported by BMWFW / aws & FFG
Initial private investments in combination with non-dilutive funding by federal institutions, supports technology setup and facilitates Ablevia's independence in seed phase. Ablevia has received funding from the Austrian Research Promotion Agency (FFG Early Stage program) and was awarded a Seedfinancing program by the Austrian promotional bank aws.
Austrian Research Promotion Agency
Location on Google Maps - here
(c) 2019 Ablevia biotech GmbH, Vienna Biocenter, Österreich
selective antibody removal therapeutics